598 related articles for article (PubMed ID: 17584993)
1. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity.
Mastalerz L; Sanak M; Gawlewicz-Mroczka A; Gielicz A; Cmiel A; Szczeklik A
Thorax; 2008 Jan; 63(1):27-34. PubMed ID: 17584993
[TBL] [Abstract][Full Text] [Related]
2. The safety of celecoxib in patients with aspirin-sensitive asthma.
Woessner KM; Simon RA; Stevenson DD
Arthritis Rheum; 2002 Aug; 46(8):2201-6. PubMed ID: 12209526
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release.
Kowalski ML; Borowiec M; Kurowski M; Pawliczak R
Allergy; 2007 Jun; 62(6):628-34. PubMed ID: 17508966
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients.
Martín-García C; Hinojosa M; Berges P; Camacho E; García-Rodriguez R; Alfaya T
J Investig Allergol Clin Immunol; 2003; 13(1):20-5. PubMed ID: 12861847
[TBL] [Abstract][Full Text] [Related]
5. Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge.
Mita H; Higashi N; Taniguchi M; Higashi A; Akiyama K
Clin Exp Allergy; 2004 Aug; 34(8):1262-9. PubMed ID: 15298568
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma.
Gaber F; Daham K; Higashi A; Higashi N; Gülich A; Delin I; James A; Skedinger M; Gyllfors P; Nord M; Dahlén SE; Kumlin M; Dahlén B
Thorax; 2008 Dec; 63(12):1076-82. PubMed ID: 18757457
[TBL] [Abstract][Full Text] [Related]
7. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs.
Zembowicz A; Mastalerz L; Setkowicz M; Radziszewski W; Szczeklik A
Arch Dermatol; 2003 Dec; 139(12):1577-82. PubMed ID: 14676074
[TBL] [Abstract][Full Text] [Related]
8. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients.
Sanak M; Kiełbasa B; Bochenek G; Szczeklik A
Clin Exp Allergy; 2004 Dec; 34(12):1899-904. PubMed ID: 15663565
[TBL] [Abstract][Full Text] [Related]
9. Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma.
Marks F; Harrell K; Fischer R
South Med J; 2001 Feb; 94(2):256-7. PubMed ID: 11235048
[TBL] [Abstract][Full Text] [Related]
10. PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease.
Wang XS; Wu AY; Leung PS; Lau HY
Allergy; 2007 Jun; 62(6):620-7. PubMed ID: 17508965
[TBL] [Abstract][Full Text] [Related]
11. Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivity.
West PM; Fernández C
Ann Pharmacother; 2003 Oct; 37(10):1497-501. PubMed ID: 14519044
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma.
Mastalerz L; Setkowicz M; Sanak M; Szczeklik A
J Allergy Clin Immunol; 2004 Apr; 113(4):771-5. PubMed ID: 15100686
[TBL] [Abstract][Full Text] [Related]
13. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.
Gray PA; Warner TD; Vojnovic I; Del Soldato P; Parikh A; Scadding GK; Mitchell JA
Br J Pharmacol; 2002 Dec; 137(7):1031-8. PubMed ID: 12429575
[TBL] [Abstract][Full Text] [Related]
14. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma.
Yoshida S; Amayasu H; Sakamoto H; Onuma K; Shoji T; Nakagawa H; Tajima T
Ann Allergy Asthma Immunol; 1998 Feb; 80(2):171-6. PubMed ID: 9494450
[TBL] [Abstract][Full Text] [Related]
15. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
[TBL] [Abstract][Full Text] [Related]
16. [Aspirin and other nonsteroidal anti-inflammatory drugs hypersensitivity--mechanisms, diagnostics and treatment].
Kupczyk M; Kuna P
Pneumonol Alergol Pol; 2008; 76(5):366-77. PubMed ID: 19003768
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.
Gyllfors P; Bochenek G; Overholt J; Drupka D; Kumlin M; Sheller J; Nizankowska E; Isakson PC; Mejza F; Lefkowith JB; Dahlén SE; Szczeklik A; Murray JJ; Dahlén B
J Allergy Clin Immunol; 2003 May; 111(5):1116-21. PubMed ID: 12743579
[TBL] [Abstract][Full Text] [Related]
18. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
[TBL] [Abstract][Full Text] [Related]
19. Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
Murphey LJ; Williams MK; Sanchez SC; Byrne LM; Csiki I; Oates JA; Johnson DH; Morrow JD
Anal Biochem; 2004 Nov; 334(2):266-75. PubMed ID: 15494133
[TBL] [Abstract][Full Text] [Related]
20. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
O'Sullivan S
Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
